The Tommy's National Rainbow Clinic Study
Launched by UNIVERSITY OF MANCHESTER · May 13, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Tommy's National Rainbow Clinic Study is looking to improve the care and support for women who have experienced the loss of a baby before or shortly after birth, a sad event that happens to about 1 in every 250 pregnancies in the UK. Many women go on to have another pregnancy after such a loss, and this study aims to provide them with the specialized support they need to feel safe and cared for during their next pregnancy. The Rainbow Clinic model offers this type of care, and the study will evaluate its effectiveness across different clinics in the UK by gathering information about women's experiences and their pregnancy outcomes.
To participate in this study, women must be currently pregnant and attending a Rainbow Clinic because they have previously experienced a stillbirth, neonatal death, or a late termination of pregnancy. Participants will be asked to fill out a short questionnaire at the beginning of their pregnancy and again at the end to help the researchers understand how the care provided affects their mental well-being and pregnancy results. This study is important because it can help improve the support offered to families during such challenging times.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women who are attending the Rainbow Clinic because they have had prior stillbirth, neonatal death or late termination of pregnancy
- • Women who are currently pregnant
- Exclusion Criteria:
- • Less than 16 years of age
- • Anyone who lacks capacity to consent
About University Of Manchester
The University of Manchester is a leading research institution known for its commitment to advancing healthcare through innovative clinical trials. With a strong emphasis on multidisciplinary collaboration, the university leverages its extensive expertise in biomedical research and clinical practice to develop and evaluate new therapies and interventions. The institution is dedicated to improving patient outcomes and public health by conducting rigorous, ethically sound trials that adhere to the highest standards of scientific integrity. Through its state-of-the-art facilities and a robust network of healthcare partnerships, the University of Manchester actively contributes to the global body of medical knowledge and the translation of research findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Manchester, Greater Manchester, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials